Menu

• Ask a Health Expert about BLOOD BETA-D-GLUCAN INCREASED
• Post Your Side Effect related to BLOOD BETA-D-GLUCAN INCREASED
• BLOOD BETA-D-GLUCAN INCREASED and FDA Warnings
• BLOOD BETA-D-GLUCAN INCREASED in Patients Wiki
• Report BLOOD BETA-D-GLUCAN INCREASED in Drug Side Effect Survey

BLOOD BETA-D-GLUCAN INCREASED side effect

What is BLOOD BETA-D-GLUCAN INCREASED ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Prograf Side Effects Report #5536720-5
Physician from JAPAN reported PROGRAF problem on Nov 19, 2007. Female patient, 69 years of age, weighting 92.64 lb, was diagnosed with rheumatoid arthritis and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: blood beta-d-glucan increased, condition aggravated, interstitial lung disease, pneumocystis jiroveci pneumonia, respiratory failure, systemic mycosis, . PROGRAF dosage: 2 MG, UID/QD, ORAL. During the same period patient was treated with RHEUMATREX, PREDNISOLONE, GASTER D ORODISPERSABLE CRLET, BAKTAR. Patient died on 10/03/2007.

Prograf Side Effects Report #5509574-0
PROGRAF problem was reported by a Physician from JAPAN on Oct 22, 2007. Female patient, 76 years of age, weighting 88.18 lb, was diagnosed with rheumatoid arthritis and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: blood beta-d-glucan increased, cardiac failure, condition aggravated, dyspnoea, eating disorder, interstitial lung disease, malaise, pleural effusion, . PROGRAF dosage: 1 MG, UID/QD; 1.5 MG, UID/QD; 2 MG, UID/QD. During the same period patient was treated with INDOMETHACIN, PREDNISONE, LANSOPRAZOLE, FOSAMAC, CANDESARTAN CILEXETIL. Patient died on 01/14/2007.

Velcade Side Effects Report #5502107-4
Physician from JAPAN reported VELCADE problem on Oct 18, 2007. Male patient, 75 years of age, weighting 127.9 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: blood beta-d-glucan increased, interstitial lung disease, neurogenic bladder, . VELCADE dosage: unknown. Patient recovered.

Prograf Side Effects Report #5504683-4
PROGRAF problem was reported by a Physician from JAPAN on Oct 17, 2007. Female patient, 27 years of age, was diagnosed with bone marrow transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: blood beta-d-glucan increased, bronchial haemorrhage, bronchopulmonary aspergillosis, haemoptysis, . PROGRAF dosage: unknown. During the same period patient was treated with PREDNISOLONE. Patient recovered.


Tacrolimus Side Effects Report #5797227-3
Physician from JAPAN reported TACROLIMUS problem on June 19, 2008. Female patient, 85 years of age, was diagnosed with lupus nephritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: blood beta-d-glucan increased, dysuria, fungus serology test positive, malnutrition, pneumonia, pulmonary mycosis, renal failure, . TACROLIMUS dosage: 1 MG, ORAL; 2 MG, ORAL; 1 MG, ORAL; 1 MG, ORAL;. During the same period patient was treated with PREDNISOLONE, ATELEC. Patient died on 02/17/2008.

Urso Side Effects Report #5353062-1
URSO problem was reported by a Consumer or non-health professional from JAPAN on May 21, 2007. Female patient, 71 years of age, was diagnosed with hepatic function abnormal, pyrexia, infection, constipation and was treated with URSO. After drug was administered, patient experienced the following problems/side effects: blood beta-d-glucan increased, blood pressure decreased, cardio-respiratory arrest, fungal infection, hepatorenal failure, hypoalbuminaemia, hypovolaemia, stevens-johnson syndrome, . URSO dosage: 300MG ORAL. During the same period patient was treated with CALONAL, LEVOFLOXACIN, LECICARBON, LASIX, FRANDOL S, GASMOTIN. Patient died.

Prograf Side Effects Report #5353679-4
Health Professional from JAPAN reported PROGRAF problem on May 30, 2007. Female patient, 68 years of age, weighting 101.4 lb, was diagnosed with rheumatoid arthritis and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: blood beta-d-glucan increased, diffuse large b-cell lymphoma, gastrointestinal necrosis, hepatic function abnormal, multi-organ failure, sepsis, splenic abscess, splenomegaly, . PROGRAF dosage: unknown. During the same period patient was treated with ENBREL, RHEUMATREX, PREDNISOLONE, ALENDRONATE, LOXONIN, RALOXIFENE. Patient was hospitalized. Patient died on 10/02/2006.

Prograf Side Effects Report #5376222-2
PROGRAF problem was reported by a Physician from JAPAN on June 18, 2007. Female patient, 76 years of age, weighting 88.18 lb, was diagnosed with rheumatoid arthritis and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: blood beta-d-glucan increased, condition aggravated, interstitial lung disease, no therapeutic response, pneumonia aspiration, pneumothorax, . PROGRAF dosage: unknown. During the same period patient was treated with INDOMETHACIN, PREDNISOLONE, LANSOPRAZOLE, FOSAMAC, BLOPRESS. Patient died.

Pentasa Side Effects Report #5314608-2
Physician from JAPAN reported PENTASA problem on Apr 13, 2007. Female patient, 34 years of age, was diagnosed with colitis ulcerative, sepsis, pyrexia and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: blood beta-d-glucan increased, cd4 lymphocytes decreased, cd8 lymphocytes decreased, colitis ulcerative, condition aggravated, decreased immune responsiveness, dehydration, gastrointestinal infection, renal impairment, . PENTASA dosage: unknown. During the same period patient was treated with MEROPEN, ROPION. Patient recovered.


Azathioprine Side Effects Report #5615715-7
AZATHIOPRINE problem was reported by a Physician from UNITED STATES on Jan 20, 2008. Male patient, 39 years of age, was diagnosed with immunosuppression and was treated with AZATHIOPRINE. After drug was administered, patient experienced the following problems/side effects: aspergillosis, blood beta-d-glucan increased, erythema, hepatic function abnormal, inflammation, necrosis, oedema peripheral, pain of skin, skin discolouration, . AZATHIOPRINE dosage: 100 MG; DAILY;. During the same period patient was treated with PREDNISONE, TACROLIMUS, ANTIBACTERIALS SYSTEMIC USE, CORTICOSTEROIDS. Patient was hospitalized. Patient recovered.

Tacrolimus Side Effects Report #5584753-5
Physician from JAPAN reported TACROLIMUS problem on Dec 21, 2007. Male patient, 77 years of age, weighting 143.3 lb, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: arrhythmia, blood beta-d-glucan increased, blood pressure decreased, bradycardia, cell marker increased, condition aggravated, disseminated intravascular coagulation, hyperkalaemia, interstitial lung disease, . TACROLIMUS dosage: 1.5 MG, UID/QD, ORAL; 2MG, UID/QD; ORAL, 3MG, UID/QD; ORAL. During the same period patient was treated with PREDNISOLONE, SIGMART, BAYASPIRINLET, CARVEDILOL, BLOPRESS, MAGLAX. Patient died on 07/15/2006.

Cytarabine Side Effects Report #5597224-7
CYTARABINE problem was reported by a Health Professional from JAPAN on Jan 14, 2008. Male patient, 17 years of age, was diagnosed with stem cell transplant and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in skin, blood beta-d-glucan increased, chest pain, chronic graft versus host disease, dyspnoea, dyspnoea exertional, hepatic function abnormal, hypogammaglobulinaemia, lymphopenia, . CYTARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, IRRADIATION, METHOTREXATE, TOSUFLOXACIN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, FLUCONAZOLE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.

Gleevec Side Effects Report #5411749-6
Physician from JAPAN reported GLEEVEC problem on Aug 08, 2007. Female patient, 76 years of age, was diagnosed with gastrointestinal stromal tumour, gastritis prophylaxis and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: anorexia, blood beta-d-glucan increased, cough, dyspnoea, interstitial lung disease, malaise, oxygen saturation decreased, . GLEEVEC dosage: 400 MG/D. During the same period patient was treated with FAMOTIDINE. Patient was hospitalized. Patient died on 06/02/2007.

Gleevec Side Effects Report #5382564-7
GLEEVEC problem was reported by a Physician from JAPAN on July 05, 2007. Female patient, 76 years of age, was diagnosed with gastrointestinal stromal tumour, gastritis prophylaxis and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: anorexia, blood beta-d-glucan increased, cough, dyspnoea, interstitial lung disease, malaise, oxygen saturation decreased, . GLEEVEC dosage: 400 MG/D. During the same period patient was treated with GASTER. Patient was hospitalized. Patient died on 06/02/2007.


Gleevec Side Effects Report #5382564-7
Physician from JAPAN reported GLEEVEC problem on July 05, 2007. Female patient, 76 years of age, was diagnosed with gastrointestinal stromal tumour, gastritis prophylaxis and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: anorexia, blood beta-d-glucan increased, cough, dyspnoea, interstitial lung disease, malaise, oxygen saturation decreased, . GLEEVEC dosage: 400 MG/D. During the same period patient was treated with GASTER. Patient was hospitalized. Patient died on 06/02/2007.

Rad Side Effects Report #5787051-X
RAD problem was reported by a Physician from JAPAN on June 16, 2008. Male patient, weighting 123.5 lb, was diagnosed with renal transplant and was treated with RAD. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, blood beta-d-glucan increased, blood creatinine increased, cytomegalovirus infection, fatigue, headache, hepatic function abnormal, musculoskeletal stiffness, pyrexia, . RAD dosage: 1.5 MG DAILY. During the same period patient was treated with NEORAL, SIMULECT, STEROIDS NOS, RABEPRAZOLE, MUCOSTA, NEGMIN GARGLE. Patient was hospitalized. Patient recovered.

Rad Side Effects Report #5787055-7
Physician from JAPAN reported RAD problem on June 16, 2008. Male patient, weighting 123.5 lb, was diagnosed with renal transplant and was treated with RAD. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, blood beta-d-glucan increased, blood creatinine increased, cytomegalovirus infection, fatigue, headache, hepatic function abnormal, musculoskeletal stiffness, pyrexia, . RAD dosage: 1.5 MG DAILY. During the same period patient was treated with NEORAL, SIMULECT, STEROIDS NOS, RABEPRAZOLE, MUCOSTA, NEGMIN GARGLE. Patient was hospitalized. Patient recovered.

Azathioprine Side Effects Report #5747238-9
AZATHIOPRINE problem was reported by a Physician from JAPAN on May 01, 2008. Female patient, 57 years of age, was diagnosed with crohn's disease and was treated with AZATHIOPRINE. After drug was administered, patient experienced the following problems/side effects: abdominal tenderness, blood beta-d-glucan increased, cough, dyspnoea, haematochezia, haemoglobin decreased, hypoxia, leukopenia, . AZATHIOPRINE dosage: 50 MG; PO. During the same period patient was treated with INFLIXIMAB, MESALAMINE, PREDNISOLONE. Patient was hospitalized. Patient recovered.

Gleevec Side Effects Report #5269992-5
Consumer or non-health professional from JAPAN reported GLEEVEC problem on Mar 13, 2007. Female patient, child 8 years of age, was diagnosed with acute lymphocytic leukaemia recurrent and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: aspergillosis, blood beta-d-glucan increased, bronchopulmonary aspergillosis, cough, malignant neoplasm progression, multi-organ failure, neutropenia, pyrexia, . GLEEVEC dosage: unknown. During the same period patient was treated with DEXAMETHASONE, VINCRISTINE SULPHATE, CYCLOPHOSPHAMIDE, CYTARABINE, IDARUBICIN, IFOSFAMIDE, FLUCONAZOLE, MICAFUNGIN. Patient died.


Ambisome Side Effects Report #5510133-4
AMBISOME problem was reported by a Health Professional from JAPAN on Sept 27, 2007. Female patient, 65 years of age, was diagnosed with febrile neutropenia and was treated with AMBISOME. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood beta-d-glucan increased, blood creatinine increased, blood urea increased, histiocytosis haematophagic, pancytopenia, . AMBISOME dosage: 100 MG, UID/QD, IV DRIP. During the same period patient was treated with RED BLOOD CELLS, MEROPEN, NEUPOGEN, PLATELETS. Patient recovered.

Steroids Side Effects Report #5524769-8
Pharmacist from JAPAN reported STEROIDS NOS problem on Nov 13, 2007. Female patient, 74 years of age, weighting 110.2 lb, was diagnosed with infection, interstitial lung disease and was treated with STEROIDS NOS. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood beta-d-glucan increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased, dehydration, fungal infection, gamma-glutamyltransferase increased, . STEROIDS NOS dosage: unknown. During the same period patient was treated with VORICONAZOLE, NEORAL. Patient recovered.

Velcade Side Effects Report #5531305-9
VELCADE problem was reported by a Physician from JAPAN on Nov 15, 2007. Male patient, 75 years of age, weighting 127.9 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, anorexia, blood beta-d-glucan increased, interstitial lung disease, neurogenic bladder, neuropathy peripheral, . VELCADE dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ALFAROL, PURSENNID, MAGNESIUM OXIDE, LANSOPRAZOLE, KYTRIL, POLYETHYLENE GLYCOL, LOPERAMIDE. Patient was hospitalized and became disabled. Patient recovered.

Metyrapone Side Effects Report #5490397-6
Consumer or non-health professional from JAPAN reported METYRAPONE problem on Oct 10, 2007. Female patient, 82 years of age, weighting 166.9 lb, was diagnosed with pituitary-dependent cushing's syndrome and was treated with METYRAPONE. After drug was administered, patient experienced the following problems/side effects: anorexia, bacterial infection, blood beta-d-glucan increased, hypoalbuminaemia, lung infiltration, malaise, oedema peripheral, pneumocystis jiroveci pneumonia, po2 decreased, . METYRAPONE dosage: 750 MG/D. During the same period patient was treated with HYDROCORTISONE. Patient was hospitalized. Patient recovered.